RESUMEN
As anorexigenic hormones bombesin and nucleobindin2 (NUCB2)/nesfatin-1 decrease food intake in rodents. Both hormones have been described in brain nuclei that play a role in the modulation of hunger and satiety, like the paraventricular nucleus of the hypothalamus (PVN) and the nucleus of the solitary tract (NTS). However, the direct interaction of the two hormones is unknown so far. The aim of study was to elucidate whether bombesin directly interacts with NUCB2/nesfatin-1 neurons in the PVN and NTS. Therefore, we injected bombesin intraperitoneally (ip) at two doses (26 and 32nmol/kg body weight) and assessed c-Fos activation in the PVN, arcuate nucleus (ARC) and NTS compared to vehicle treated rats (0.15M NaCl). We also performed co-localization studies with oxytocin or tyrosine hydroxylase. Bombesin at both doses increased the number of c-Fos positive neurons in the PVN (p<0.05) and NTS (p<0.05) compared to vehicle, while in the ARC no modulation was observed (p>0.05). In the PVN and NTS the number of c-Fos positive neurons colocalized with NUCB2/nesfatin-1 increased after bombesin injection compared to vehicle treatment (p<0.05). Moreover, an increase of activated NUCB2/nesfatin-1 immunoreactive neurons that co-expressed oxytocin in the PVN (p<0.05) or tyrosine hydroxylase in the NTS (p<0.05) was observed compared to vehicle. Our results show that peripherally injected bombesin activates NUCB2/nesfatin-1 neurons in the PVN and NTS giving rise to a possible interaction between bombesin and NUCB2/nesfatin-1 in the modulation of food intake.
Asunto(s)
Bombesina/metabolismo , Proteínas de Unión al Calcio/metabolismo , Proteínas de Unión al ADN/metabolismo , Ingestión de Alimentos/fisiología , Proteínas del Tejido Nervioso/metabolismo , Animales , Núcleo Arqueado del Hipotálamo/metabolismo , Bombesina/fisiología , Proteínas de Unión al Calcio/fisiología , Proteínas de Unión al ADN/fisiología , Hipotálamo/metabolismo , Masculino , Proteínas del Tejido Nervioso/fisiología , Neuronas/metabolismo , Nucleobindinas , Oxitocina , Núcleo Hipotalámico Paraventricular/metabolismo , Proteínas Proto-Oncogénicas c-fos/metabolismo , Ratas , Ratas Sprague-Dawley , Núcleo Solitario/metabolismo , Tirosina 3-MonooxigenasaRESUMEN
PURPOSE OF REVIEW: To highlight the research progress of roles of bombesin-like peptides and their receptors in pharmacology and physiology. RECENT FINDINGS: Several new bombesin-derived radioactive or nonradioactive compounds were designed for the diagnosis and therapy of tumors that are overexpressing bombesin receptors. Both gastrin-releasing peptide receptor and neuromedin B receptor activation were shown to induce membrane depolarization and excite neurons in brain. Bombesin receptor subtype-3 was found to be downregulated in the muscle cells and myocytes from obese and type 2 diabetes patients, and its relevant cell signaling events in glucose homeostasis were also investigated. The molecular events triggered by bombesin receptors activation in different types of malignancies is being explored recently and new clues were provided for a better understanding of the biological roles of abnormal expression of bombesin receptors in tumors. Novel cross-talk between gastrin-releasing peptide receptor cell signaling and Sonic hedgehog pathways was identified in small-cell lung carcinoma. SUMMARY: Increasing evidence shows bombesin-like peptides and their receptors play important roles in both physiological state and diseases. More specific and safe tumor targeting Bombesin derivatives are being developed for tumor diagnosis and therapy.
Asunto(s)
Antineoplásicos/farmacología , Bombesina/farmacología , Péptido Liberador de Gastrina/farmacología , Neoplasias Pulmonares/terapia , Músculo Esquelético/metabolismo , Fragmentos de Péptidos/farmacología , Receptores de Bombesina/fisiología , Carcinoma Pulmonar de Células Pequeñas/terapia , Biomarcadores de Tumor , Bombesina/fisiología , Regulación hacia Abajo , Péptido Liberador de Gastrina/antagonistas & inhibidores , Péptido Liberador de Gastrina/fisiología , Humanos , Péptidos y Proteínas de Señalización Intracelular , Fragmentos de Péptidos/fisiología , Células Tumorales CultivadasRESUMEN
We have previously shown that the intraperitoneal (i.p.) administration of gastrin-releasing peptide-27 (GRP-27) or bombesin (BN) (at 0.21, 0.41 and 1.03nmol/kg) reduces meal size (MS) and prolongs the intermeal interval (IMI). Here, we hypothesized that the intravenous (i.v.) administration of the same doses of GRP-27 and BN will be as effective as the i.p. administration in evoking these feeding responses. To test this hypothesis, we administered GRP-27 and BN i.v. and measured first MS (10% sucrose), IMI, satiety ratio (SR, IMI/MS) and second MS in overnight food-deprived but not water-deprived male Sprague Dawley rats. We found that (1) only GRP-27 reduced the first MS, (2) BN prolonged the IMI, (3) GRP-27 and BN increased the SR and (4) only BN reduced the size of the second meal. Contrary to our hypothesis, the i.v. administration of GRP-27 and BN affected the MS and IMI differently than did the i.p. administration. In conclusion, this pharmacological study suggests that the MS and IMI are regulated at different sites.
Asunto(s)
Bombesina/fisiología , Péptido Liberador de Gastrina/fisiología , Animales , Apetito , Bombesina/administración & dosificación , Ingestión de Energía , Conducta Alimentaria , Péptido Liberador de Gastrina/administración & dosificación , Infusiones Intravenosas , Masculino , Ratas , Ratas Sprague-Dawley , SaciedadRESUMEN
OBJECTIVES: Neuropeptides are important signal initiators in advanced prostate cancer, partially acting through activation of nuclear factor kappa B. Central to nuclear factor kappa B regulation is the ubiquitin-proteasome system, pharmacological inhibition of which has been proposed as an anticancer strategy. We investigated the putative role of the proteasome inhibitor bortezomib in neuropeptides signaling effects on prostate cancer cells. METHODS: Human prostate cancer cell lines, LNCaP and PC-3, were used to examine cell proliferation, levels of proapoptotic (caspase-3, Bad) and cell cycle regulatory proteins (p53, p27, p21), as well as total and phosphorylated Akt and p44/42 mitogen-activated protein kinase proteins. Furthermore, 20S proteasome activity, subcellular localization of nuclear factor kappa B and transcription of nuclear factor kappa B target genes, interleukin-8 and vascular endothelial growth factor, were assessed. RESULTS: Neuropeptides (endothelin-1, bombesin) increased cell proliferation, whereas bortezomib decreased proliferation and induced apoptosis, an effect maintained after cotreatment with neuropeptides. Bad, p53, p21 and p27 were downregulated by neuropeptides in PC-3, and these effects were reversed with the addition of bortezomib. Neuropeptides increased proteasomal activity and nuclear factor kappa B levels in PC-3, and these effects were prevented by bortezomib. Interleukin-8 and vascular endothelial growth factor transcripts were induced after neuropeptides treatment, but downregulated by bortezomib. These results coincided with the ability of bortezomib to reduce mitogen-activated protein kinase signaling in both cell lines. CONCLUSIONS: These findings are consistent with bortezomib-mediated abrogation of neuropeptides-induced proliferative and antiapoptotic signaling. Thus, the effect of the drug on the neuropeptides axis needs to be further investigated, as neuropeptide action in prostate cancer might entail involvement of the proteasome.
Asunto(s)
Antineoplásicos/farmacología , Apoptosis/efectos de los fármacos , Bombesina/efectos de los fármacos , Ácidos Borónicos/farmacología , Proliferación Celular/efectos de los fármacos , Endotelina-1/efectos de los fármacos , Neoplasias de la Próstata/patología , Pirazinas/farmacología , Bombesina/fisiología , Bortezomib , Línea Celular Tumoral , Inhibidor p21 de las Quinasas Dependientes de la Ciclina/efectos de los fármacos , Inhibidor p21 de las Quinasas Dependientes de la Ciclina/fisiología , Inhibidor p27 de las Quinasas Dependientes de la Ciclina/efectos de los fármacos , Inhibidor p27 de las Quinasas Dependientes de la Ciclina/fisiología , Regulación hacia Abajo , Endotelina-1/fisiología , Humanos , Interleucina-8/efectos de los fármacos , Interleucina-8/genética , Masculino , Proteínas Quinasas Activadas por Mitógenos/efectos de los fármacos , FN-kappa B/efectos de los fármacos , FN-kappa B/fisiología , Complejo de la Endopetidasa Proteasomal/efectos de los fármacos , Complejo de la Endopetidasa Proteasomal/fisiología , ARN Mensajero/metabolismo , Transducción de Señal/efectos de los fármacos , Translocación Genética/efectos de los fármacos , Proteína p53 Supresora de Tumor/efectos de los fármacos , Proteína p53 Supresora de Tumor/fisiología , Factor A de Crecimiento Endotelial Vascular/efectos de los fármacos , Factor A de Crecimiento Endotelial Vascular/genética , Proteína Letal Asociada a bcl/efectos de los fármacos , Proteína Letal Asociada a bcl/fisiologíaRESUMEN
PURPOSE OF REVIEW: This review will highlight recent advances in the understanding of mammalian bombesin receptor-related pathophysiological roles in disease states and new insights into bombesin receptor pharmacology. RECENT FINDINGS: Studies regarding bombesin-like peptides and mammalian bombesin receptor functions have demonstrated significant biological impact on a broad array of physiological and pathophysiological conditions. Pharmacological experiments in vitro and in vivo as well as utilization of genetic rodent models of the gastrin-releasing peptide receptor (GRP-R/BB2) and neuromedin B receptor (NMB-R/BB1) further delineated roles in memory and fear behavior, inhibition of tumor cell growth, mediating signals for pruritus and male reproductive behavior. All three mammalian bombesin receptors were shown to possess some role in the regulation of energy balance. Novel synthesis of selective high affinity agonists and antagonists of the orphan bombesin receptor subtype-3 (BRS-3/BB3) has been accomplished and will facilitate further studies using animal model systems. SUMMARY: Mammalian bombesin receptors participate in the regulation of energy homeostasis and may represent an attractive target for pharmacological treatment of obesity and certain eating disorders. Novel pharmacological insights of bombesin-like peptides and the interaction with their respective receptors have been elucidated to aid future treatment and imaging of epithelial cell-derived tumors.
Asunto(s)
Bombesina/química , Bombesina/fisiología , Hormonas Peptídicas/fisiología , Receptores de Bombesina/fisiología , Animales , Bombesina/metabolismo , Antagonistas de Hormonas/química , Antagonistas de Hormonas/farmacología , Humanos , Masculino , Mamíferos , Metabolismo/genética , Metabolismo/fisiología , Hormonas Peptídicas/química , Hormonas Peptídicas/metabolismo , Preparaciones Farmacéuticas/química , Receptores de Bombesina/antagonistas & inhibidores , Receptores de Bombesina/genética , Receptores de Bombesina/metabolismo , RoedoresRESUMEN
We recently reported a previously unknown peptidergic system within the lumbosacral spinal cord that uses gastrin-releasing peptide (GRP) to trigger erection and ejaculation in male rats. Many men suffering from stress, including posttraumatic stress disorder (PTSD) and major depressive disorder, report sexual dysfunction. Sexual dysfunction in men suffering from stress and major depressive disorder is traditionally treated via psychological counseling. To determine whether acute severe stress could alter the male-specific GRP system, we used single prolonged stress (SPS) exposure in a putative rat model for PTSD. Exposure of male rats to SPS decreases the local content and the axonal distribution of GRP in the lower lumbar spinal cord and results in an attenuation of penile reflexes in vivo. Pharmacological stimulation of GRP receptors remarkably restores penile reflexes in SPS-exposed male rats and in castrated male rats. The administration of a GRP agonist to these animal models interestingly induces spontaneous ejaculation in a dose-dependent manner. Furthermore, although the circulating level of androgens is normal 1 week after SPS exposure, there is a significant decrease in the expression of androgen receptor protein in lumbar segments 3 and 4 of the spinal cord. This might make the spinal center less responsive to androgens. In this report, I review findings on a recently identified spinal GRP system that could be vulnerable to stress and that controls male reproductive function. This system provides new insights into the clinical treatment of psychogenic erectile dysfunction triggered by stress and psychiatric disorders.
Asunto(s)
Disfunción Eréctil/etiología , Disfunción Eréctil/fisiopatología , Péptido Liberador de Gastrina/fisiología , Médula Espinal/fisiopatología , Estrés Psicológico/complicaciones , Andrógenos/fisiología , Animales , Bombesina/fisiología , Modelos Animales de Enfermedad , Eyaculación/fisiología , Humanos , Masculino , Erección Peniana/fisiología , Ratas , Trastornos por Estrés Postraumático/complicacionesRESUMEN
Bombesin and related peptides are widely distributed in gastrointestinal tract and central nervous system. It has been reported that they play an important role in the control of appetite, metabolism, sensory transmission and thermoregulation as well as in the regulation of pituitary hormone release. Central injection of these peptides leads to inhibition of feeding. There are controversial opinions about the effects of bombesin on pituitary hormone secretion both in vivo and in vitro experiments.
Asunto(s)
Bombesina/fisiología , Metabolismo Energético/fisiología , Hormonas Hipofisarias/metabolismo , Animales , Metabolismo Energético/genética , Homeostasis/genética , Homeostasis/fisiología , Humanos , Sistema Hipotálamo-Hipofisario/metabolismoRESUMEN
During tissue regeneration and wound healing of the skin, migration, proliferation and differentiation of keratinocytes are important processes. Here we assessed the effect of a neuropeptide, bombesin, on keratinocytes during regeneration from scratch wounding. Bombesin purified from amphibian skin, is homologous of mammalian gastrin-releasing peptide and is active in mammals. Its pharmacological effects mediate various physiological activities: hypertensive action, stimulating action on gastric secretion, hyperglycemic effect or increased insulin secretion. In vitro it shows a hyperproliferative effect on different experimental models and is involved in skin repair. The aim of this study was to elucidate the effect of Bombesin in an in vitro experimental model on a mechanically injured human keratinocyte monolayer. We evaluated different mediators involved in wound repair such as IL-8, TGFbeta, IL-1, COX-2, VEGF and Toll-like receptors 2 and 4 (TLR2 and TLR4). We also studied the effects of bombesin on cell proliferation and motility and its direct effect on wound repair by observing the wound closure after mechanical injury. The involvement of the bombesin receptors neuromedin receptor (NMBR) and gastrin-releasing peptide receptor (GRP-R) was also evaluated. Our data suggest that bombesin may have an important role in skin repair by regulating the expression of healing markers. It enhanced the expression of IL-8, TGFbeta, COX-2 and VEGF. It also enhanced the expression of TLR2, while TLR4 was not expressed. Bombesin also increased cell growth and migration. In addition, we showed that NMBR was more involved in our experimental model compared to GRP-R.
Asunto(s)
Bombesina/farmacología , Bombesina/fisiología , Cicatrización de Heridas/efectos de los fármacos , Animales , Anuros , Bombesina/aislamiento & purificación , Diferenciación Celular/efectos de los fármacos , Línea Celular , Movimiento Celular/efectos de los fármacos , Supervivencia Celular/efectos de los fármacos , Colorantes/metabolismo , Ciclooxigenasa 2/metabolismo , Relación Dosis-Respuesta a Droga , Evaluación Preclínica de Medicamentos , Humanos , Interleucina-18/metabolismo , Interleucina-8/metabolismo , Queratinocitos/citología , Queratinocitos/efectos de los fármacos , Queratinocitos/fisiología , Receptores de Bombesina/análisis , Receptores de Bombesina/metabolismo , Factores de Tiempo , Receptor Toll-Like 2/metabolismo , Receptor Toll-Like 4/metabolismo , Factor de Crecimiento Transformador beta/metabolismo , Azul de Tripano/metabolismo , Factor A de Crecimiento Endotelial Vascular/metabolismo , Cicatrización de Heridas/fisiologíaRESUMEN
PURPOSE OF REVIEW: Mammalian bombesin-related peptides, gastrin-releasing peptide and neuromedin B actions are mediated by two receptors (BB1-receptor, BB2-receptor), which are closely related to the orphan receptor BRS-3 (BB3-receptor). The purpose of this review is to highlight advances in the understanding of these peptides in physiology/disease states. RECENT FINDINGS: Pharmacologic/receptor-knockout studies show involvement of these receptors in a number of new processes/diseases. Neuromedin B/BB1-receptor is an important physiological regulator of pituitary-thyroid function; in mediating behavior, especially feas/anxiety; in mediating satiety through different cascades than gastrin-releasing peptide/BB2 receptors and for its autocrine tumor-growth effects. Gastrin-releasing peptide/BB2-receptor plays important roles in mediating signals for pruritus, lung development/injury, small intestinal mucosal defense, and central nervous system processes such as learning/memory. The signaling mechanisms of its potent growth effects are being elucidated and their possible therapeutic targets identified. BB3-receptor knockout mice provided insights for their obesity/glucose intolerance and demonstrated that this receptor may be important in the lung response to injury, tumor growth and gastrointestinal motility. Each receptor is frequently overexpressed in human tumors and has potent growth effects. This effect is being explored to develop new antitumor treatments, such as bombesin-receptor ligands conjugated to cytotoxic agents. SUMMARY: This receptor family is involved in an increasing number of central nervous system/peripheral processes physiologically and in disease states, and increased understanding of its role may lead to novel treatments.
Asunto(s)
Bombesina/fisiología , Fragmentos de Péptidos/fisiología , Receptores de Bombesina/fisiología , Animales , Antineoplásicos/uso terapéutico , Bombesina/química , Bombesina/metabolismo , Bombesina/farmacología , Proliferación Celular/efectos de los fármacos , Humanos , Neoplasias/tratamiento farmacológico , Fragmentos de Péptidos/metabolismo , Fragmentos de Péptidos/farmacología , Fragmentos de Péptidos/uso terapéuticoRESUMEN
RATIONALE: The incidence of bronchopulmonary dysplasia (BPD), a chronic lung disease of newborns, is paradoxically rising despite medical advances. We demonstrated elevated bombesin-like peptide levels in infants that later developed BPD. In the 140-day hyperoxic baboon model of BPD, anti-bombesin antibody 2A11 abrogated lung injury. OBJECTIVES: To test the hypothesis that bombesin-like peptides mediate BPD in extremely premature baboons (born at Gestational Day 125 and given oxygen pro re nata [PRN], called the 125-day PRN model), similar to "modern-day BPD." METHODS: The 125-day animals were treated with 2A11 on Postnatal Day 1 (P1), P3, and P6. On P14 and P21, lungs were inflation-fixed for histopathologic analyses of alveolarization. Regulation of angiogenesis by bombesin was evaluated using cultured pulmonary microvascular endothelial cells. MEASUREMENTS AND MAIN RESULTS: In 125-day PRN animals, urine bombesin-like peptide levels at P2-3 are directly correlated with impaired lung function at P14. Gastrin-releasing peptide (the major pulmonary bombesin-like peptide) mRNA was elevated eightfold at P1 and remained high thereafter. At P14, 2A11 reduced alveolar wall thickness and increased the percentage of secondary septa containing endothelial cells. At P21, 2A11-treated 125-day PRN animals had improved alveolarization according to mean linear intercepts and number of branch points per millimeter squared. Bombesin promoted tubulogenesis of cultured pulmonary microvascular endothelial cells, but cocultured fetal lung mesenchymal cells abrogated this effect. CONCLUSIONS: Early bombesin-like peptide overproduction in 125-day PRN animals predicted alveolarization defects weeks later. Bombesin-like peptide blockade improved septation, with the greatest effects at P21. This could have implications for preventing BPD in premature infants.
Asunto(s)
Bombesina/fisiología , Displasia Broncopulmonar/patología , Péptido Liberador de Gastrina/fisiología , Neovascularización Patológica/etiología , Alveolos Pulmonares/crecimiento & desarrollo , Animales , Animales Recién Nacidos , Displasia Broncopulmonar/metabolismo , Técnicas de Cultivo de Célula , Modelos Animales de Enfermedad , Células Endoteliales/fisiología , Humanos , Recién Nacido , Papio , ARN Mensajero/metabolismoRESUMEN
Over the last two decades, several lines of experimental evidence have suggested that the gastrin-releasing peptide (GRP) may act as a growth factor in many types of cancer. For that reason, gastrin-releasing peptide receptor (GRPR) antagonists have been developed as anticancer candidate compounds, exhibiting impressive antitumoral activity both in vitro and in vivo in various murine and human tumors. In this article, the GRPR cell surface expression profile in human malignancies is reviewed aiming at the identification of potential tumor types for future clinical trials with GRP analogues and antagonists. In this review, we summarize the current literature regarding the GRPR status in human malignancies. Source data were obtained by searching all published material available through Medline, PubMed and relevant articles from 1971 to 2006. The data available demonstrated a high expression of GRPRs in a large spectrum of human cancers, demonstrating the potential relevance of this intracellular signaling pathway in various human tumor models. The GRPR may be an interesting target for therapeutic intervention in human malignancies, as carriers for cytotoxins, immunotoxins or radioactive compounds, being also a potential tool for tumor detection.
Asunto(s)
Antineoplásicos/uso terapéutico , Receptores de Bombesina/antagonistas & inhibidores , Bombesina/fisiología , Ensayos Clínicos como Asunto , Sistemas de Liberación de Medicamentos , Factor de Crecimiento Epidérmico/antagonistas & inhibidores , Humanos , Neoplasias/metabolismo , Transducción de Señal/efectos de los fármacos , Factor A de Crecimiento Endotelial Vascular/antagonistas & inhibidoresRESUMEN
The increasing prevalence of obesity has triggered intense research on its pharmacotherapy. Besides central neuroendocrine pathways, many peripheral endocrino-metabolic signals have been investigated, but only few are probably of some utility in weight loss. This review reports about ghrelin and other gastrointestinal peptides involved in hunger and satiety.
Asunto(s)
Bombesina/fisiología , Colecistoquinina/fisiología , Ingestión de Energía , Péptido 1 Similar al Glucagón/fisiología , Hambre/fisiología , Hormonas Peptídicas/fisiología , Péptido YY/fisiología , GhrelinaRESUMEN
Cyclooxygenase-2 (Cox-2), the gastrin-release peptide (GRP) and its cognate receptor (GRP-R) are overexpressed in a significant percentage of colorectal carcinomas and are associated with cell growth, invasiveness and tumor progression. However, a molecular link between all of them in adenocarcinomas has not been established. Here, we show that bombesin (BBS), a GRP homolog, stimulates the expression of Cox-2 mRNA and protein in human colon adenocarcinoma Caco-2 cells, resulting in enhanced release of prostaglandin E(2). These effects were markedly inhibited by the specific BBS antagonist RC-3940-II. BBS promotes the activation of the nuclear factor of activated T cells (NFAT) through a Ca(2+)/calcineurin (Cn)-linked pathway. Upon BBS stimulation, the NFATc1 isoform translocates into the nucleus with a concomitant increase in NFATc1 binding to two specific recognition sites in the promoter region of the Cox-2 gene. Furthermore, inhibition of Cn activity by the immunosuppressive drug cyclosporin A impaired NFAT activation and diminished Cox-2 expression in BBS-stimulated cells. Interestingly, BBS pretreatment strongly enhances the invasive capacity of carcinoma cells, effect which was inhibited by a Cox-2-specific inhibitor. These findings provide the first evidence for the involvement of the Ca(2+)/Cn/NFAT pathway in BBS-mediated induction of genes involved in colon carcinoma invasiveness such as Cox-2.
Asunto(s)
Adenocarcinoma/enzimología , Adenocarcinoma/patología , Bombesina/fisiología , Movimiento Celular/fisiología , Neoplasias del Colon/enzimología , Neoplasias del Colon/patología , Ciclooxigenasa 2/biosíntesis , Factores de Transcripción NFATC/metabolismo , Transporte Activo de Núcleo Celular/fisiología , Adenocarcinoma/metabolismo , Células CACO-2 , Calcineurina/fisiología , Neoplasias del Colon/metabolismo , Ciclooxigenasa 2/genética , Proteínas de Unión al ADN/metabolismo , Inducción Enzimática/fisiología , Humanos , Invasividad Neoplásica/patología , Transducción de Señal/fisiologíaRESUMEN
We investigated whether either heterozygous (HET) or homozygous (knockout, KO) disruption of the melanocortin type 4 receptor (MC4R) gene alters post ingestive responsiveness of mice. Specifically, we tested the hypothesis that hyperphagia in MC4RKO mice might be due to a deficit in processes that sustain intermeal intervals (satiety) and/or processes that terminate ongoing episodes of eating (satiation). To test satiety, mice drank an oral preload and then we monitored intake of a subsequent liquid diet test meal. To test satiation, we examined the effect of exogenous administration of cholecystokinin (CCK) and bombesin (BN) on the size of a liquid diet meal. Experiment 1 was comprised of two studies. In the first, we determined that the intake of all three genotypes following fasts of either 6, 12, or 24h were comparable, and so chose 12h deprivation for the subsequent studies. In the second, 12h fasted mice were allowed to consume a fixed preload, approximately 50% of their expected mean intake and, following delays of either 30 or 60 min, were allowed to consume to satiation. Compared with no preload, the preload significantly reduced meal size comparably in all three genotypes. The reduction in intake was greater when the test meal was presented 30 compared with 60 min after the preload, again with no genotype differences in this decay of satiety. In experiment 2, we administered either CCK or BN and examined suppression of meal size after a 12h fast. Mice were tested repeatedly with CCK-8 (2, 6, or 18 microg/kg ip) or BN (2, 4 or 8 microg/kg ip) with vehicle injection days intervening. The 30 min intakes of HET and KO mice were suppressed more than those of WT following either CCK or BN. These experiments suggest that diminished responsiveness to nutrients or gut satiety hormones is not responsible for hyperphagia in MC4RKO mice.
Asunto(s)
Bombesina/fisiología , Colecistoquinina/fisiología , Ingestión de Alimentos/genética , Receptor de Melanocortina Tipo 4/genética , Animales , Bombesina/administración & dosificación , Colecistoquinina/administración & dosificación , Hiperfagia/genética , Ratones , Ratones Noqueados , Receptor de Melanocortina Tipo 4/deficiencia , Respuesta de Saciedad/fisiologíaRESUMEN
AIM: To investigate the influence of experimental obstructive jaundice and exogenous bombesin (BBS) and neurotensin (NT) administration on the expression of the tight junction (TJ)-protein claudin-4 in intestinal epithelium of rats. METHODS: Forty male Wistar rats were randomly divided into five groups: I = controls, II = sham operated, III = bile duct ligation (BDL), IV = BDL+BBS (30 microg/kg per d), V = BDL+NT (300 microg/kg per d). At the end of the experiment on d 10, endotoxin was measured in portal and aortic blood. Tissue sections of the terminal ileum were examined histologically and immunohistochemically for evaluation of claudin-4 expression in intestinal epithelium. RESULTS: Obstructive jaundice led to intestinal barrier failure demonstrated by significant portal and aortic endotoxemia. Claudin-4 expression was significantly increased in the upper third of the villi in jaundiced rats and an upregulation of its lateral distribution was noted. Administration of BBS or NT restored claudin-4 expression to the control state and significantly reduced portal and aortic endotoxemia. CONCLUSION: Experimental obstructive jaundice increases claudin-4 expression in intestinal epithelium, which may be a key factor contributing to the disruption of the mucosal barrier. Gut regulatory peptides BBS and NT can prevent this alteration and reduce portal and systemic endotoxemia.
Asunto(s)
Bombesina/farmacología , Mucosa Intestinal/química , Mucosa Intestinal/efectos de los fármacos , Ictericia Obstructiva/fisiopatología , Proteínas de la Membrana/análisis , Neurotensina/farmacología , Neurotransmisores/farmacología , Animales , Bilirrubina/sangre , Bombesina/fisiología , Permeabilidad de la Membrana Celular/fisiología , Claudina-4 , Endotoxinas/sangre , Regulación de la Expresión Génica/efectos de los fármacos , Regulación de la Expresión Génica/fisiología , Inmunohistoquímica , Mucosa Intestinal/patología , Ictericia Obstructiva/sangre , Ictericia Obstructiva/genética , Masculino , Proteínas de la Membrana/genética , Neurotensina/fisiología , Neurotransmisores/fisiología , Ratas , Ratas Wistar , Uniones Estrechas/química , Uniones Estrechas/fisiologíaRESUMEN
The neuropeptides bombesin and endothelin-1 stimulate prostate cancer (PC) cell migration and invasion (J Clin Invest, 2000; 106: 1399-1407). The intracellular signaling pathways that direct this cell movement are not well delineated. The monomeric GTPase RhoA is required for migration in several cell types including neutrophils, monocytes and fibroblasts. We demonstrate that bombesin-stimulated PC cell migration occurs via the heterotrimeric G-protein-coupled receptors (G-protein) G alpha 13 subunit leading to activation of RhoA, and Rho-associated coiled-coil forming protein kinase (ROCK). Using siRNA to suppress expression of the three known G-protein alpha-subunit-associated RhoA guanine nucleotide exchange factors (GEFs), we also show that two of these RhoA GEFs, PDZ-RhoGEF and leukemia-associated RhoGEF (LARG), link bombesin receptors to RhoA in a non-redundant manner in PC cells. We next show that focal adhesion kinase, which activates PDZ-RhoGEF and LARG, is required for bombesin-stimulated RhoA activation. Neutral endopeptidase (NEP) is expressed on normal prostate epithelium whereas loss of NEP expression contributes to PC progression. We also demonstrate that NEP inhibits neuropeptide activation of RhoA. Together, these results establish a contiguous signaling pathway from the bombesin receptor to ROCK in PC cells, and they implicate NEP as a major regulator of neuropeptide-stimulated RhoA in these cells. This work also identifies members of this signaling pathway as potential targets for rational pharmacologic manipulation of neuropeptide-stimulated migration of PC cells.
Asunto(s)
Movimiento Celular/fisiología , Neprilisina/fisiología , Neuropéptidos/fisiología , Neoplasias de la Próstata/enzimología , Transducción de Señal/fisiología , Proteína de Unión al GTP rhoA/fisiología , Bombesina/fisiología , Línea Celular Tumoral , Citoesqueleto/metabolismo , Endotelina-1/fisiología , Activación Enzimática/fisiología , Humanos , Masculino , Neoplasias de la Próstata/patologíaRESUMEN
Amphibian bombesin and its related peptides consist a family of neuropeptides in many vertebrate species. Bombesin and two major bombesin-like peptide in mammals, gastrin-releasing peptide (GRP) and neuromedin B (NMB), have been shown to elicit various physiological effects. These include inhibition of feeding, smooth muscle contraction, exocrine and endocrine secretions, thermoregulation, blood pressure and sucrose regulations and cell growth. Receptors for GRP and NMB (GRP-R and NMB-R), as well as third subtype of bombesin-like peptide receptor (BRS-3) have been cloned. These receptors are G-protein-coupled receptors and are expressed in various brain regions and in the digestive tract. In this paper, we will summarize studies on these peptides and their receptors, with special reference to research using gene-knockout mice. These studies clearly demonstrated the role of three receptors in vivo and in vitro. We will also discuss the phylogeny of these receptors.
Asunto(s)
Bombesina/fisiología , Receptores de Bombesina/fisiología , Secuencia de Aminoácidos , Anfibios , Animales , Bombesina/genética , Química Encefálica , Pollos , Clonación Molecular , Secuencia Conservada , Humanos , Ratones , Datos de Secuencia Molecular , Ratas , Receptores de Bombesina/genética , Alineación de Secuencia , Homología de Secuencia de AminoácidoRESUMEN
As we commemorate the 25th anniversary of the journal Peptides, it is timely to review the functional significance of the bombesin (BB)-like peptides and receptors in the CNS. Over two decades ago we published an article in the journal Peptides demonstrating that BB-like peptides are present in high densities in certain rat brain regions (such as the paraventricular nucleus of the hypothalamus). Subsequently, one of the mammalian forms of BB, gastrin-releasing peptide (GRP) containing cell bodies were found in the suprachiasmatic nucleus of the hypothalamus and nucleus of the solitary tract of the hindbrain. Another related peptide, namely neuromedin (NM)B, was detected in the olfactory bulb and dentate gyrus. BB and GRP bind with high affinity to BB(2) receptors, whereas NMB binds with high affinity to BB(1) receptors. The actions of BB or GRP are blocked by BB(2) receptor antagonists such as (Psi(13,14)-Leu(14))BB whereas PD168368 is a BB(1) receptor antagonist. Exogenous administration of BB into the rat brain causes hypothermia, hyperglycemia, grooming and satiety. BB-like peptides activate the sympathetic nervous system and appear to modulate stress, fear and anxiety responses. GRP and NMB modulate distinct biological processes through discrete brain regions or circuits, and globally these peptidergic systems may serve in an integrative or homeostatic function.
Asunto(s)
Conducta Animal/fisiología , Bombesina/fisiología , Encéfalo/fisiología , Neuroquinina B/análogos & derivados , Receptores de Bombesina/fisiología , Animales , Conducta Animal/efectos de los fármacos , Bombesina/farmacología , Conducta Alimentaria/efectos de los fármacos , Conducta Alimentaria/fisiología , Neuroquinina B/genética , Neuroquinina B/fisiología , RatasRESUMEN
BACKGROUND: Little is known of the molecular events leading to increased intestinal permeability in obstructive jaundice. This study was undertaken to investigate the influence of experimental obstructive jaundice on the expression of the tight junction-associated protein occludin in the intestinal epithelium. STUDY DESIGN: Seventy male Wistar rats were randomly divided into five groups: I, controls; II, sham-operated; III, bile duct ligation (BDL); IV, BDL+Bombesin (BBS) (30 microg/kg/d); and V, BDL+Neurotensin (NT) (300 microg/kg/d). At the end of the experiment, on day 10, endotoxin was measured in portal and aortic blood. Tissue sections of the terminal ileum were examined histologically and immunohistochemically for evaluation of occludin expression in the intestinal epithelium. Lipid peroxidation and protein oxidation were determined on tissue homogenates from terminal ileum and microbiologic analysis was performed in cecal contents. RESULTS: Obstructive jaundice resulted in portal and aortic endotoxemia, which was significantly reduced after BBS or NT administration. In the BDL group, there was total loss of occludin expression in numerous enterocytes mainly at the upper third of the villi, while a gradient of positivity existed from crypt to tip. Occludin expression was restored to control state after treatment with BBS or NT. In addition, both peptides reduced intestinal lipid peroxidation, while BBS reduced protein oxidation as well. CONCLUSIONS: Experimental obstructive jaundice induces regional loss of occludin expression in the intestinal epithelium, which may be a key factor contributing to the disruption of the mucosal barrier. Gut regulatory peptides BBS and NT prevent this alteration, leading to lower portal and systemic endotoxemia.
Asunto(s)
Bombesina/fisiología , Mucosa Intestinal/metabolismo , Mucosa Intestinal/patología , Ictericia Obstructiva/metabolismo , Proteínas de la Membrana/metabolismo , Neurotensina/fisiología , Animales , Bilirrubina/sangre , Conducto Colédoco/cirugía , Modelos Animales de Enfermedad , Endotoxinas/sangre , Ictericia Obstructiva/patología , Ligadura , Masculino , Ocludina , Distribución Aleatoria , Ratas , Ratas WistarRESUMEN
BACKGROUND: A pathway consisting of bombesin, G-protein coupling receptors (GPCRs), metalloproteases, pro-heparin-binding epidermal growth factor (proHB-EGF), and epidermal growth factor receptor (EGFR) has been reported in prostate cancer cells. The occurrence of HB-EGF shedding from proHB-EGF in this pathway, however, has not been proven directly. In addition, it is still unclear how much this pathway contributes to the migration of prostate cancer cells. In this study, we tried to directly elucidate HB-EGF shedding in this pathway and to determine its contribution to the migration of prostate cancer cells. METHODS: RT-PCR and indirect immunofluorescence staining for HB-EGF and its receptors, such as EGFR and HER4/erbB4, were performed on PC-3 cells. The influences of bombesin, anti-EGFR neutralizing monoclonal antibody, HB-EGF, and HB-EGF shedding inhibitor on the migration of PC-3 cells were studied by means of in vitro wound assays. The amount of HB-EGF shed from PC-3 cells with alkaline phosphatase-tagged HB-EGF in the presence of bombesin was determined by measuring AP activity. Immunoprecipitations and phosphotyrosine Western blotting were performed to detect EGFR transactivated by bombesin. RESULTS: PC-3 expressed HB-EGF and EGFR, but not HER4/erbB4. PC-3 migrated in the presence of bombesin, but its migration was partly inhibited by the neutralizing antibody against EGFR. PC-3 also migrated in the presence of HB-EGF, but HB-EGF shedding inhibitor partly inhibited this phenomenon. HB-EGF was shed from PC-3 cells in the presence of bombesin, and this shedding was inhibited by HB-EGF shedding inhibitor. In addition, the EGFR on PC-3 was activated in the presence of bombesin and inactivated in the presence of HB-EGF shedding inhibitor. CONCLUSIONS: These results indicated that HB-EGF shedding and the following transactivation of EGFR occurs in this pathway and that this pathway partly contributes to the migration of prostate cancer cells.